Remidio, RetinaRisk partner to improve AI-driven Diabetic Retinopathy Screening This partnership brings together Remidio’s Medios DR AI for automated DR detection and RetinaRisk’s personalised risk triaging…
Remidio invests in Occuity to advance non-invasive disease screening in India The partnership will focus on early myopia detection, portable eye disease screening, and non-invasive diabetes monitoring
Kerala Govt, Remidio launch Nayanamritham 2.0, an AI-assisted chronic eye disease screening… The programme extends across community health centres, taluk hospitals, and district hospitals, making comprehensive eye care…
